Brainsway Ltd.
Medical technology company
BWAY Tel Aviv Stock Exchange · home listing
Tel Aviv Stock Exchange
BWAY Nasdaq
ISIN IL0011007189 SEC CIK 1505065
Follow Brainsway Ltd.
Weekly email: filings, results
EPS, diluted
-
Source: SEC XBRL filings · latest filing
- Revenue
- Net income
Show the numbers
| Year | Revenue | Net income |
|---|---|---|
| FY24 | $41M | $2.9M |
| FY23 | $31.8M | −$4.2M |
| FY22 | $27.2M | −$13.3M |
| FY21 | $29.7M | −$6.5M |
| FY20 | $22.1M | −$5.4M |
| FY19 | $23.1M | −$10.3M |
| FY18 | $16.4M | −$6.5M |
| FY17 | $11.1M | −$7.1M |
| FY16 | - | - |
- Gross margin
- Operating margin
- Net margin
Show the numbers
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| FY24 | 74.6% | 3.4% | 7.1% |
| FY23 | 73.9% | −15.6% | −13.2% |
| FY22 | 73.8% | −46.7% | −49.1% |
| FY21 | 77.7% | −16.9% | −21.8% |
| FY20 | 77.1% | −21.9% | −24.4% |
| FY19 | 77.8% | −36.7% | −44.7% |
| FY18 | 78.1% | −31.2% | −39.5% |
| FY17 | 76.7% | −59.3% | −63.3% |
| FY16 | - | - | - |
Show the numbers
| Year | Free cash flow |
|---|---|
| FY24 | - |
| FY23 | - |
| FY22 | - |
| FY21 | −$1.4M |
| FY20 | −$3.9M |
| FY19 | −$10.6M |
| FY18 | −$5.7M |
| FY17 | −$4.5M |
| FY16 | - |
- Brainsway Ltd.
- Healthcare median
Show the numbers
| Year | Brainsway Ltd. | Healthcare median |
|---|---|---|
| FY24 | 7.1% | −47% |
| FY23 | −13.2% | −58% |
| FY22 | −49.1% | −80.4% |
| FY21 | −21.8% | −71.9% |
| FY20 | −24.4% | −62.2% |
| FY19 | −44.7% | −46.3% |
| FY18 | −39.5% | −49.6% |
| FY17 | −63.3% | −45.9% |
| FY16 | - | −36% |